“…Risk of Bias assessment reported that eleven studies (69%) ( DeGroff et al, 2001 ; Yang et al, 2002 ; Bhatikar et al, 2005 ; De Vos and Blanckenberg, 2007 ; Ye et al, 2011 ; Zhang and Pohl, 2015 ; Karar et al, 2017 ; Pereira et al, 2017 ; Meza et al, 2018 ; Diller et al, 2019a ; Bahado-Singh et al, 2020 ) had high risk of patient selection bias due to the study design (case control) while the remaining five studies (31%) ( Higuchi et al, 2006 ; Gharehbaghi et al, 2015 ; Gavrovska et al, 2016 ; Kotb et al, 2016 ; Sepehri et al, 2016 ) were unclear risk. The index test interpretation bias was unclear in nine studies (56%) ( DeGroff et al, 2001 ; Yang et al, 2002 ; Bhatikar et al, 2005 ; Higuchi et al, 2006 ; De Vos and Blanckenberg, 2007 ; Gharehbaghi et al, 2015 ; Sepehri et al, 2016 ; Pereira et al, 2017 ; Diller et al, 2019a ), high in six studies (37%) ( Ye et al, 2011 ; Zhang and Pohl, 2015 ; Gavrovska et al, 2016 ; Karar et al, 2017 ; Meza et al, 2018 ; Bahado-Singh et al, 2020 ) and low in only one study (7%) ( Kotb et al, 2016 ). The main contributor to the unclear risk was the unavailability of information regarding theblinding status in these studies.…”